Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.03 USD | +3.22% | +25.82% | +7.37% |
May. 02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
Financials (USD)
Sales 2024 * | 551M | Sales 2025 * | 587M | Capitalization | 1.73B |
---|---|---|---|---|---|
Net income 2024 * | -174M | Net income 2025 * | -193M | EV / Sales 2024 * | 2.75 x |
Net cash position 2024 * | 212M | Net Debt 2025 * | 234M | EV / Sales 2025 * | 3.34 x |
P/E ratio 2024 * |
-10.1
x | P/E ratio 2025 * |
-9.11
x | Employees | 1,453 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.74% |
Latest transcript on NovoCure Limited
1 day | +3.22% | ||
1 week | +25.82% | ||
Current month | +30.96% | ||
1 month | +13.05% | ||
3 months | +7.95% | ||
6 months | +32.92% | ||
Current year | +7.37% |
Managers | Title | Age | Since |
---|---|---|---|
Asaf Danziger
CEO | Chief Executive Officer | 56 | 01-12-31 |
Ashley Cordova
DFI | Director of Finance/CFO | 45 | 14-05-31 |
Moshe Giladi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Doyle
CHM | Chairman | 61 | 03-12-31 |
Kin Yip Leung
BRD | Director/Board Member | 62 | 11-08-04 |
David Hung
BRD | Director/Board Member | 66 | 18-05-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.81% | 0 M€ | 0.00% | - | |
0.71% | 0 M€ | 0.00% | - | |
0.19% | 0 M€ | +5.54% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 16.03 | +3.22% | 1,002,438 |
24-05-07 | 15.53 | -0.13% | 904,588 |
24-05-06 | 15.55 | +5.21% | 1,285,557 |
24-05-03 | 14.78 | +4.16% | 1,145,704 |
24-05-02 | 14.19 | +11.38% | 1,575,580 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.37% | 1.73B | |
+73.50% | 12.41B | |
-19.26% | 7.87B | |
+2.40% | 6.37B | |
+3.66% | 5.81B | |
+11.89% | 5.36B | |
+37.45% | 4.92B | |
-19.73% | 4.02B | |
-35.58% | 2.43B | |
+0.74% | 2.02B |
- Stock Market
- Equities
- NVCR Stock